Notable Labs Corp (NTBL) - Operatsion rentabellik

Ommaviy kompaniya Notable Labs Corp (NTBL) logotipi

Notable Labs, Ltd. (NTBL) kompaniyasining investitsiya potentsiali shaxsiylashtirilgan terapiyaga e'tibor qaratish uchun AI algoritmlarini ishlab chiqishni tashqi hamkorlarga autsorsing qilishga asoslangan. Operatsion foyda marjalari ushbu yondashuvni aks ettiradi, bunda 0.00 darajasi so'nggi qiymatlarni qamrab oladi. Samaradorlik masshtablanuvchi, yuqori marjali o'smalarni tahlil qilish dasturiy ta'minoti va aksiyalar opsion tizimi orqali noyob mutaxassislarni saqlab qolish bilan tasdiqlanadi.

NTBL: Notable Labs Ltd Sotuvning operatsion rentabelligi 21.02.2024 - 02.11.2024

Notable Labs, Ltd. (NTBL) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

- aksiya narxi va baholash bo'yicha konsensus prognoz:
Kompaniyaning asosiy tahlili:Notable Labs Inc., NTBL
Notable Labs Corp asosiy tovari

Aniq onkologiya innovatori Notable Labs, Ltd. (NTBL) uchun uning bashorat platformasining tijorchashtirish samaradorligi bevosita operatsion marjada aks etadi. Ushbu operatsion rentabellik moliyaviy xarajatlar va soliqlardan oldin asosiy biznes operatsiyalaridan olingan foyda ulushini o'lchaydi, bu esa investorlarga tashqi marketing shovqinlarini istisno qilgan holda, kompaniyaning o'ziga xos terapiya tanlash jarayonidan pul oqimini yaratishning haqiqiy qobiliyatini baholash imkonini beradi.

Muhim raqobatchilar

Operatsion rentabellik BeiGene Ltd|Halozyme Therapeutics - Operatsion foyda marjasi|Sotuvning operatsion marjasi RVMD (Revolution Medicines Corp)|Operatsion foyda koeffitsiyenti AAPG|Operatsion rentabellik CG Oncology Therapeutics CGON|Operatsion foyda normasi URGN|BCAX: Sotuvning operatsion marjasi|PSNL: Operatsion rentabellik|Erasca (ERAS) - Operatsion rentabellik|DCTH - Operatsion faoliyat rentabelligi|YMAB (Y-mAbs Corp) - Operatsion marja|Sotuvning operatsion marjasi Aura Biosciences (AURA)|Operatsion rentabellik Candel Therapeutics Inc. (CADL)|Sotuvning operatsion marjasi Accuray, Inc. ARAY|Operatsion rentabellik sellaslifesciences.com SLS|Operatsion foyda normasi ACTU|CTOR - Operatsion rentabellik|Operatsion faoliyat rentabelligi tuhurabio.com HURA|Protara Therapeutics, Inc. (TARA) - Operatsion rentabellik|FATE: Operatsion foyda koeffitsiyenti|WHWK (Aadi Bioscience, Inc.) - Operatsion marja|TCRX (TScan Therapeutics) - Operatsion foyda koeffitsiyenti|Operatsion rentabellik Champions Oncology (CSBR)|Operatsion faoliyat rentabelligi XBiotech USA|Operatsion rentabellik CEL-SCI CVM|OS Therapies, Inc. (OSTX) - Sotuvning operatsion rentabelligi|RADX - Operatsion rentabellik|ARTV - Operatsion marja|Adlai Nortye Ltd (ANL) - Operatsion rentabellik|Veru Pharma - Operatsion foyda normasi|Operatsion rentabellik Tempest Therapeutics Corp|Operatsion foyda bo'yicha sotuv rentabelligi XLO (Xilio Therapeutics, Inc.)|Operatsion marja RENB|MURA (Mural Oncology) - Operatsion foyda normasi|Operatsion marja KAPA (Kairos Pharma Ltd)|OKUR: Operatsion foyda bo'yicha sotuv rentabelligi|GDTC: Sotuvning operatsion marjasi|CRIS - Operatsion marja|APLM: Operatsion marja|Sotuvning operatsion rentabelligi tharimmune.com (THAR)|ADVB (Advanced Biomed Corp) - Operatsion marja|Operatsion marja Genprex Inc.|Operatsion marja CLDI|Sotuvning operatsion marjasi Sunshine Biopharma, Inc. SBFM|Operatsion marja XBIO (Xenetic Biosciences)|Operatsion foyda normasi SLRX|PPBT - Operatsion rentabellik|AONC (aoncology.com) - Operatsion foyda bo'yicha sotuv rentabelligi|BGNE: Operatsion marja|Checkpoint Therapeutics Inc (CKPT) - Operatsion marja|ELEV (Elevation Oncology Inc.) - Operatsion marja|icadmed.com (ICAD) - Operatsion faoliyat rentabelligi|Operatsion marja IKNA|VIRX (Viracta Therapeutics, Inc.) - Operatsion foyda normasi|Operatsion rentabellik MorphoSys Corporation MOR|NAYA: Operatsion foyda bo'yicha sotuv rentabelligi|Ascentage Pharma Group International - Operatsion marja